| scholarly article | Q13442814 |
| P2093 | author name string | Hui Zheng | |
| Cheng Zhang | |||
| Juan Li | |||
| Xiao Xiao | |||
| Jianbin Li | |||
| Chunping Qiao | |||
| Zhenhua Yuan | |||
| Chi-Hsien Wang | |||
| P2860 | cites work | Congenital muscular dystrophy with abnormal radiographic myelin pattern | Q48496183 |
| NeuN: a useful neuronal marker for diagnostic histopathology | Q48912555 | ||
| Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. | Q51659718 | ||
| Efficient retrograde neuronal transduction utilizing self-complementary AAV1 | Q64376808 | ||
| Polyclonal antisera to the individual neurofilament triplet proteins: a characterization using ELISA and immunoblotting | Q69681060 | ||
| Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man | Q75310510 | ||
| Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus | Q24523073 | ||
| Intramuscular viral delivery of paraplegin rescues peripheral axonopathy in a model of hereditary spastic paraplegia | Q24534210 | ||
| Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system | Q28141743 | ||
| NeuN, a neuronal specific nuclear protein in vertebrates | Q28510657 | ||
| A novel transcript overlapping the myelin basic protein gene | Q33187304 | ||
| Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy | Q33793572 | ||
| Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin | Q33922811 | ||
| Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases | Q34092603 | ||
| Use of HSV vectors to modify the nervous system. | Q34583042 | ||
| Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: a strategy to increase opioid antinociception | Q35023218 | ||
| Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. | Q35025591 | ||
| Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain | Q36458975 | ||
| Gene therapy for peripheral nervous system diseases | Q36985449 | ||
| Herpes vector-mediated gene transfer in the treatment of chronic pain | Q37035292 | ||
| AAV for pain: steps towards clinical translation | Q37406976 | ||
| Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth | Q40036426 | ||
| Laminin alpha1 chain improves laminin alpha2 chain deficient peripheral neuropathy | Q40300149 | ||
| A combination of mutations enhances the neurotropism of AAV-2. | Q40384910 | ||
| Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport | Q40680080 | ||
| Development and application of herpes simplex virus vectors for human gene therapy | Q40945227 | ||
| Schwann cell myelination occurred without basal lamina formation in laminin alpha2 chain-null mutant (dy3K/dy3K) mice | Q42507557 | ||
| Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes | Q42739394 | ||
| Expression of mouse agrin in normal, denervated and dystrophic muscle | Q44473154 | ||
| Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors | Q44492885 | ||
| Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system | Q45007196 | ||
| Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice | Q45397001 | ||
| Neonatal intraperitoneal or intravenous injections of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neurons | Q45398907 | ||
| Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart | Q45507049 | ||
| Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice | Q45731049 | ||
| Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization | Q45742577 | ||
| P433 | issue | 1 | |
| P921 | main subject | vector-borne disease | Q2083837 |
| P304 | page(s) | 87-97 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Human Gene Therapy | Q15757580 |
| P1476 | title | Efficient retrograde transport of adeno-associated virus type 8 to spinal cord and dorsal root ganglion after vector delivery in muscle | |
| P478 | volume | 21 |
| Q58799022 | A-Type K Channels in Dorsal Root Ganglion Neurons: Diversity, Function, and Dysfunction |
| Q47564638 | AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials |
| Q33764228 | AAV-Mediated Gene Transfer to Dorsal Root Ganglion |
| Q38190041 | Adeno-associated virus vectors and neurological gene therapy |
| Q35430864 | Development of viral vectors for gene therapy for chronic pain |
| Q35219215 | Fast-conducting mechanoreceptors contribute to withdrawal behavior in normal and nerve injured rats |
| Q94503876 | Gene Transfer in Rodent Nervous Tissue Following Hindlimb Intramuscular Delivery of Recombinant Adeno-Associated Virus Serotypes AAV2/6, AAV2/8, and AAV2/9 |
| Q30539495 | Gene transfer in skeletal and cardiac muscle using recombinant adeno-associated virus |
| Q59360695 | Human carbonic anhydrase-8 AAV8 gene therapy inhibits nerve growth factor signaling producing prolonged analgesia and anti-hyperalgesia in mice |
| Q34189539 | In vivo gene knockdown in rat dorsal root ganglia mediated by self-complementary adeno-associated virus serotype 5 following intrathecal delivery |
| Q34321271 | Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice. |
| Q39124150 | Intraperitoneal administration of AAV9-shRNA inhibits target gene expression in the dorsal root ganglia of neonatal mice |
| Q37181416 | Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease |
| Q37065567 | Intraspinal AAV Injections Immediately Rostral to a Thoracic Spinal Cord Injury Site Efficiently Transduces Neurons in Spinal Cord and Brain. |
| Q42246858 | Intrathecal administration of IGF-I by AAVrh10 improves sensory and motor deficits in a mouse model of diabetic neuropathy |
| Q45324668 | Lentiviral vectors and adeno-associated virus vectors: useful tools for gene transfer in pain research |
| Q64082902 | On the development of optical peripheral nerve interfaces |
| Q54217659 | Optogenetic Control of Neural Circuits in the Mongolian Gerbil. |
| Q35898470 | Optophysiological analysis of associational circuits in the olfactory cortex |
| Q33586940 | Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9. |
| Q39591013 | Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration |
| Q36775253 | Selective Manipulation of Neural Circuits |
| Q59355422 | Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus Macaques |
| Q38029645 | Viral vectors and delivery strategies for CNS gene therapy |
Search more.